Benitec Biopharma Limited Weighted Average Shares Diluted Growth

Weighted Average Shares Diluted Growth of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Weighted Average Shares Diluted Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Weighted Average Shares Diluted Growth for the quarter ending June 30, 2022 was -1.0 (a -238.4% decrease compared to previous quarter)
  • Year-over-year quarterly Weighted Average Shares Diluted Growth decreased by -100.02%
  • Annual Weighted Average Shares Diluted Growth for 2022 was 0.9 (a -190.37% decrease from previous year)
  • Annual Weighted Average Shares Diluted Growth for 2021 was -1.0 (a -100.04% decrease from previous year)
  • Annual Weighted Average Shares Diluted Growth for 2021 was 2659.12 (a -266437.76% decrease from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Weighted Average Shares Diluted Growth of Benitec Biopharma Limited

Most recent Weighted Average Shares Diluted Growthof BNTC including historical data for past 10 years.

Interactive Chart of Weighted Average Shares Diluted Growth of Benitec Biopharma Limited

Benitec Biopharma Limited Weighted Average Shares Diluted Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -1.0 0.72 0.9
2021 1199.44 4300.58 5059.69 2775.53 -1.0
2020 -0.98 0.4 -0.99 -0.99 -1.0
2019 -0.76 -0.28 -1.0
2018 -0.68
2017 113.67 -1.0
2016 89.46 -1.0
2015 0.28
2014 -0.91
2013 10.53

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology